Cytovia Therapeutics and Cellectis Partner to Develop TALEN® Gene-Edited iPSC-Derived Natural Killer Cells

NEXT STORY
Czech Republic First European Country to Grant National Authorisation for the Use of Telix’s Prostate Cancer Imaging Product
PREV STORY
Novavax Announces Expanded Collaboration and License Agreement with SK Bioscience for 40 Million Doses of COVID-19 Vaccine for South Korea
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Nabriva Therapeutics Receives Positive EU CHMP Opinion for XENLETA™ (lefamulin) for the Treatment of Community-Acquired Pneumonia (CAP)

author_avatar
NASDAQ Market News

Tampa General Hospital announces strategic partnership with Philips to innovate and improve patient experience

author_avatar
NASDAQ Market News

Generex Biotechnology Subsidiary NuGenerex Diagnostics Announces Sales for its Rapid Point-of-Care Malaria Diagnostic Test Kit

author_avatar
NASDAQ Market News